Indeed - wonderful to have colleagues such as @joannespetz.bsky.social who are willing to step up and support essential care for women's health!

Editor's Choice @Health_Affairs Scholar. Lack of U.S. Policy Research Funded by the National Institute of Mental Health, 1993-2024 academic.oup.com/healthaffair...

Editor's Choice @Health_Affairs Scholar - more evidence re drug costs! Impact on hospitals of price reductions for physician-administered biologics academic.oup.com/healthaffair...

Editor's Choice @Health_Affairs Scholar. Private equity in health care very timely topic! Practitioner's guide to using data on private equity hospital acquisitions academic.oup.com/healthaffair...

Editor's Choice @Health_Affairs Scholar! very topical - see special report on PBS Newshour. Patient and Staff Safety Implications of Emergency Department Boarding: A Systematic Review academic.oup.com/healthaffair...

The U.S. administration has dismissed the National Science Board, the body that advises the National Science Foundation. Read the full statement from AAAS: https://bit.ly/4eHKg1whttps://bit.ly/4eHKg1w

Insurers are not directly the primary cause of health spending growth. But, with major insurers posting strong profits as health care costs grow, it’s reasonable to ask what value they provide for the overhead they consume.

Thanks to Dr Faust for posting this. One way to get transparency. open.substack.com/pub/insideme...

Every year, we look forward to the ISPOR annual conference as an opportunity to share our work and learn more from our colleagues working in health economics outcomes research (HEOR). Click here for the full lineup of ICER speakers: icer.org/news-insight... #ISPORAnnual #ISPOR2026 #HEOR #hta

Fascinating review of how discovery AND investment together moved precision medicine forward. Next frontiers MRD and MCED. www.discoveriesinhealthpolicy.com/2026/04/the-...

Important article re debate on most favored nation pricing! Policymakers should be cautious about adopting pricing policies that would implicitly subject US pharmaceutical spending to benchmarks developed in different institutional and fiscal contexts @Health_Affairs Scholar

So sad www.nytimes.com/2026/04/21/o...

“HOPE” – it was thrill of lifetime to see @brucespringsteen.net in concert yesterday – reminded me when met Presidential candidate @barackobama.bsky.social years ago. 2 men fighting for hope, democracy, faith, dreams!

Insightful panel that touched on many key issues on scientific publication with honest insights. EICs from @jama.com @Science @nejm.org @kbibbinsdomingo.bsky.social @holdenthorp.bsky.social www.aaas.org/news/editors...

Why do we invest billions in drugs, BUT far less in the diagnostics needed to ensure they’re used effectively? That question motivated our new Science paper on diagnostics, innovation, and disease burden www.science.org/eprint/7B2DE...

In Science, we argue that w/o the right tests best medicines make no difference. Advances in obesity & Alzheimer's drugs outpacing tests needed to guide their use. Regulatory & payment reforms needed! @robcaliff.bsky.social @daneahorn.bsky.social #SciencePolicyForum www.science.org/eprint/7B2DE...

Excellent list of lessons learned that can be generalized. Lessons learned .... behind the first over-the-counter daily birth control pill in the United States and recommended strategies for implementing full insurance coverage - Contraception www.contraceptionjournal.org/article/S001...

Publication in @Health_Affairs Scholar - 2 giants in the field @bobkocher @Bob_Wachter "impact of AI may be enabling an entirely new class of clinicians organized around disease biology and patient needs" academic.oup.com/healthaffair...

Important new study @UCSF. Corporate Vectors of Chronic Disease — Using Internal Industry Documents to Craft Counterstrategies | New England Journal of Medicine www.nejm.org/doi/10.1056/...

What an honor to hear @GabbyGiffords and @SpeakerPelosi speak out against gun violence. @GIFFORDS_org

Succinct summary of key @icer_review findings - 5 takeaways, 5 questions published in @Health_Affairs Scholar!

Opening with a quote from Carl Sagan, a U.S. district court in Massachusetts issued a 45-page temporary injunction that BLOCKS some of the anti-vaccine decisions from Health Secretary RFK Jr. Gift link: www.nytimes.com/2026/03/16/h... (1/2🧵)

Fascinating!

Good explanation

Interesting

Surprising

Available NOW -- Today, the Health Economics Methods Advisory Group (HEMA) released its inaugural report: “Defining appropriate benefits for economic evaluation of health care technologies.” hemamethods.org/2026/03/11/h...

New article on timely issue @healthaffairs Scholar What Do We Really Know About Addressing Burnout Among Healthcare Workers? Maybe Less Than We Think url: academic.oup.com/healthaffair...

Silicon Valley company's stock nosedives by 50% after cancer test trial www.sfgate.com/bayarea/arti...

CEVR's 2025 "By the Numbers" highlights our impressive output for last year:

Fascinating! New approach roughly predicts when Alzheimer’s symptoms begin www.washingtonpost.com/health/2026/...

And read this letter too! www.wsj.com/opinion/the-...

New publication @Health_Affairs Scholar gives 5 actions to improve journals’ research integrity using AI in manuscript review. Let's commit to transparent/equitable AI use! Using AI to Improve Peer-review and Research Integrity in Scientific Journals. academic.oup.com/healthaffair...

This March 7th we are rallying for a second time in D.C. and nationwide! Join the fight by visiting standupforscience.net/march7 or fuel the fight for science by visiting standupforscience.net/donate Thank you! #March7 #standupforscience #ImpeachRFKJr #RemoveRFKJr #science

The NIH has lost its scientific integrity. So we left www.statnews.com/2026/01/10/n... via @statnews

Worth reading! Unsafe, Not Effective, $3.2 Million Per Dose: Why Is This Drug Still Available? | Health Affairs www.healthaffairs.org/content/fore...

@Health_Affairs Scholar welcomes rigorous research on complex and controversial policy topics to deepen discussion. See article by CMS officials on Medicare Advantage payments, cited 2_10 in @WSJ editorial. @OxfordJournals academic.oup.com/healthaffair...

Join UCSF IHPS and The Lundberg Institute on March 9, online or in-person, as Robert Hiatt, MD, PhD gives a @cwclub.bsky.social talk, What Diversity, Equity, and Inclusion Mean for the Health Sciences, and Why Big Data Needs Them All www.commonwealthclub.org/events/2026-...

Congress passes legislation creating pathway for Medicare coverage of MCED - with key caveats - FDA approval, initially only if <68, www.congress.gov/bill/119th-c...

Could this saga be coming to a close? Trump Is Said to Have Dropped Demand for Cash From Harvard www.nytimes.com/2026/02/02/u...

Will really miss David Brooks NY Times! Always so thoughtful and down to earth www.nytimes.com/2026/01/30/o...

We Do Care | New England Journal of Medicine www.nejm.org/doi/full/10....

My pleasure to be on the Health Affairs podcast talking about the "Great American Healthcare Plan" - er....non-plan? Vision board (h/t Jeff). Hope you enjoy! www.healthaffairs.org/do/10.1377/h...

This is bonkers. I think I would take the rest of the year off if everything I worked on for the last two years was gone. If you regularly use AI / ChatGPT (and probably others) you need to read this.

Oh no, this is an unfortunate problem for NIH and genetics research - requires careful and proactive response. Genetic Data From Over 20,000 U.S. Children Misused for ‘Race Science’. www.nytimes.com/2026/01/24/u...

Should be great webinar by Health Affairs: The FDA and Its Changing Relationship to Industry. www.healthaffairs.org/do/10.1377/h...

Insightful assessment @brucequinnmd on recent publication on how Medicare’s 2018 National Coverage Determination affected claim denials for next-generation sequencing www.discoveriesinhealthpolicy.com/2026/01/jour...

How can FDA continue to support innovation? Publication by NASEM committee members S. Dhruva, @hollylynchez.bsky.social @dusetzinas.bsky.social, myself argue for post-marketing evidence, validation of surrogate markers, adherence to standards, ensuring resources. academic.oup.com/healthaffair...

Good!